The FDA told Reata that the clinical data do not show that the drug, bardoxolone, slows the progression of the loss of kidney function in patients who have the rare disease Alport syndrome. The regulatory decision follows an FDA advisory committee vote recommending against approval of the small molecule drug.
ViVE 2022, powered by HLTH and CHIME, will convene top thought leaders who are shaping tech-enabled healthcare and addressing key issues in digital health innovation. Save $150 with code medcity150!
Vektor Health will implement its vMap technology at UC San Diego. Its device uses 12-lead electrocardiogram (ECG) data to flag potential sources of arrhythmia anywhere in the heart.
By Michael Schroeder Sunday, February 27, 2022 12:00 PM
Nearly two years into the pandemic, only about 1 in 4 Americans, less than 26%, have used telehealth, according to Trilliant Health's 2022 Telehealth Trends Report. Getting past the industry hype, a deeper analysis of the marketplace shows the universal appeal isn't there; but there's still demand for it.
By Anna Kamen and Dan Gebremedhim Sunday, February 27, 2022 10:00 AM
To combat challenges facing the industry, both policymakers and entrepreneurs have been working on complementary strategies to help primary care physicians, nephrologists and other care team members disrupt the status quo.
By Sameer Khanna Sunday, February 27, 2022 9:00 AM
Many healthcare companies are examining ways to incorporate AI to improve safety, efficiency and the overall patient experience. However, as companies continue to prioritize this technology, it's important to focus on finding the right applications, rather than just using it to replace humans.
No comments